S&P 500   4,963.90 (-0.23%)
DOW   38,490.08 (-0.19%)
QQQ   423.96 (-0.79%)
AAPL   182.49 (+0.51%)
MSFT   399.62 (-0.79%)
META   464.89 (-1.35%)
GOOGL   141.39 (+0.19%)
AMZN   167.65 (+0.34%)
TSLA   195.71 (+1.01%)
NVDA   680.20 (-2.06%)
NIO   6.07 (+1.85%)
AMD   162.74 (-1.78%)
BABA   75.42 (+3.12%)
T   16.92 (+0.06%)
F   12.19 (-0.49%)
MU   80.33 (-0.47%)
CGC   3.35 (-5.37%)
GE   149.04 (+0.28%)
DIS   108.26 (-1.08%)
AMC   4.65 (-0.21%)
PFE   27.42 (-0.62%)
PYPL   58.02 (-1.04%)
XOM   104.22 (+1.43%)
S&P 500   4,963.90 (-0.23%)
DOW   38,490.08 (-0.19%)
QQQ   423.96 (-0.79%)
AAPL   182.49 (+0.51%)
MSFT   399.62 (-0.79%)
META   464.89 (-1.35%)
GOOGL   141.39 (+0.19%)
AMZN   167.65 (+0.34%)
TSLA   195.71 (+1.01%)
NVDA   680.20 (-2.06%)
NIO   6.07 (+1.85%)
AMD   162.74 (-1.78%)
BABA   75.42 (+3.12%)
T   16.92 (+0.06%)
F   12.19 (-0.49%)
MU   80.33 (-0.47%)
CGC   3.35 (-5.37%)
GE   149.04 (+0.28%)
DIS   108.26 (-1.08%)
AMC   4.65 (-0.21%)
PFE   27.42 (-0.62%)
PYPL   58.02 (-1.04%)
XOM   104.22 (+1.43%)
S&P 500   4,963.90 (-0.23%)
DOW   38,490.08 (-0.19%)
QQQ   423.96 (-0.79%)
AAPL   182.49 (+0.51%)
MSFT   399.62 (-0.79%)
META   464.89 (-1.35%)
GOOGL   141.39 (+0.19%)
AMZN   167.65 (+0.34%)
TSLA   195.71 (+1.01%)
NVDA   680.20 (-2.06%)
NIO   6.07 (+1.85%)
AMD   162.74 (-1.78%)
BABA   75.42 (+3.12%)
T   16.92 (+0.06%)
F   12.19 (-0.49%)
MU   80.33 (-0.47%)
CGC   3.35 (-5.37%)
GE   149.04 (+0.28%)
DIS   108.26 (-1.08%)
AMC   4.65 (-0.21%)
PFE   27.42 (-0.62%)
PYPL   58.02 (-1.04%)
XOM   104.22 (+1.43%)
S&P 500   4,963.90 (-0.23%)
DOW   38,490.08 (-0.19%)
QQQ   423.96 (-0.79%)
AAPL   182.49 (+0.51%)
MSFT   399.62 (-0.79%)
META   464.89 (-1.35%)
GOOGL   141.39 (+0.19%)
AMZN   167.65 (+0.34%)
TSLA   195.71 (+1.01%)
NVDA   680.20 (-2.06%)
NIO   6.07 (+1.85%)
AMD   162.74 (-1.78%)
BABA   75.42 (+3.12%)
T   16.92 (+0.06%)
F   12.19 (-0.49%)
MU   80.33 (-0.47%)
CGC   3.35 (-5.37%)
GE   149.04 (+0.28%)
DIS   108.26 (-1.08%)
AMC   4.65 (-0.21%)
PFE   27.42 (-0.62%)
PYPL   58.02 (-1.04%)
XOM   104.22 (+1.43%)

Cyclo Therapeutics (CYTHW) News Today

$0.31
0.00 (0.00%)
(As of 02/20/2024 ET)
SourceHeadline
businesswire.com logoCyclo Therapeutics Announces Publication of Positive Data from Phase 2 Clinical Study of Trappsol ® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1
businesswire.com - June 29 at 8:22 PM
finance.yahoo.com logoCyclo Therapeutics Announces Publication of Positive Data from Phase 2 Clinical Study of Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1
finance.yahoo.com - June 29 at 3:22 PM
Get Cyclo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYTHW and its competitors with MarketBeat's FREE daily newsletter.



CYTHW Media Mentions By Week

CYTHW Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYTHW
News Sentiment

0.00

0.53

Average
Medical
News Sentiment

CYTHW News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYTHW Articles
This Week

0

0

CYTHW Articles
Average Week

Get Cyclo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYTHW and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CYTHW) was last updated on 2/21/2024 by MarketBeat.com Staff